1. Home
  2. KRC vs IRTC Comparison

KRC vs IRTC Comparison

Compare KRC & IRTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Kilroy Realty Corporation

KRC

Kilroy Realty Corporation

HOLD

Current Price

$33.94

Market Cap

4.4B

Sector

Real Estate

ML Signal

HOLD

Logo iRhythm Technologies Inc.

IRTC

iRhythm Technologies Inc.

SELL

Current Price

$107.22

Market Cap

3.7B

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
KRC
IRTC
Founded
1947
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Medical/Dental Instruments
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
4.4B
3.7B
IPO Year
1996
2016

Fundamental Metrics

Financial Performance
Metric
KRC
IRTC
Price
$33.94
$107.22
Analyst Decision
Hold
Strong Buy
Analyst Count
17
15
Target Price
$40.14
★ $175.21
AVG Volume (30 Days)
★ 1.3M
496.9K
Earning Date
10-22-2026
11-05-2026
Dividend Yield
★ 6.49%
N/A
EPS Growth
31.07
★ 61.71
EPS
★ N/A
N/A
Revenue
★ $1,112,667,000.00
$747,138,000.00
Revenue This Year
N/A
$18.70
Revenue Next Year
$2.16
$17.79
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ 26.24
52 Week Low
$27.36
$100.85
52 Week High
$43.58
$210.01

Technical Indicators

Market Signals
Indicator
KRC
IRTC
Relative Strength Index (RSI) 40.58 36.09
Support Level $33.71 $107.33
Resistance Level $34.36 $125.38
Average True Range (ATR) 0.62 3.73
MACD 0.01 -0.13
Stochastic Oscillator 54.51 13.64

Price Performance

Historical Comparison
KRC
IRTC

About KRC Kilroy Realty Corporation

Kilroy Realty is a premier owner and landlord of approximately 16.3 million square feet of office space across Los Angeles, San Diego, the San Francisco Bay Area, Austin, Texas, and greater Seattle. The company operates as a real estate investment trust.

About IRTC iRhythm Technologies Inc.

iRhythm Holdings Inc is a digital healthcare company that creates trusted solutions that detect, predict, and prevent disease. Its principal business is the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services that it believes allow clinicians to diagnose certain arrhythmias quicker and with greater efficiency than other services that rely on traditional technology. Each Zio System combines an FDA-cleared and CE-marked, wire-free, patch-based, 14-day wearable biosensor that continuously records electrocardiogram (ECG) data with a proprietary, FDA-cleared, CE-marked cloud-based data analytic software to help physicians monitor patients and diagnose arrhythmias.

Share on Social Networks: